Although the direct mechanisms by which APG modulates ALDH1A2 expression in ALS have not yet been fully elucidated, targeting ALDH1A2 with APG could provide a valuable therapeutic approach in counteracting ALS-related oxidative stress and cell apoptosis, supporting this study’s hypothesis. The gene discussed is ALDH1A2; the disease is amyotrophic lateral sclerosis.